CABA: Cabaletta Bio Inc. filed SEC Form 8-K: Other Events
Stocks in this Quantisnow insightHealth Care
Historical context for CABA
Across the 14 sessions after earlier CABA headlines, the stock closed higher 7 times and lower 7 times, with a median move of 5.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CABA | SPY |
|---|---|---|---|
| Sep 1, 2026 | Cabaletta Bio to Participate in Upcoming Investor Conferences | +6.1% | -0.7% |
| Aug 13, 2026 | Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update | -4.9% | +0.7% |
| Jun 3, 2026 | Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress | -2.7% | -0.7% |
| May 14, 2026 | Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Updateand 1 other headline that session | +0.6% | +0.8% |
| May 4, 2026 | Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering | +30.3% | -0.4% |
| Apr 28, 2026 | Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-celand 2 other headlines that session | -1.7% | -0.5% |
Quantisnow market dataNASDAQ
CABA
Cabaletta Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2019
Get push alerts for CABA
Full CABA profile on Quantisnow Follow CABA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time